WHO and PATH publish toolkit on strategies to address MDR-TB
WHO and PATH have published a toolkit designed to help countries develop or strengthen the multidrug-resistant tuberculosis (MDR-TB) components within national TB strategies or plans.
The toolkit contains guidance on the key steps of the planning process, including developing objectives, identifying current gaps in service coverage, securing funding sources and determining how to monitor progress.
The toolkit is aimed at countries, technical partners, international organizations, and donors who want to improve the detection and treatment of drug-resistant TB.
A MDR-TB assessment and monitoring tool, on which the new toolkit is based, is also available in English, Russian, and Spanish.
Stop TB Partnership
